Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Plos Medicine
Fang, Si S; Yarmolinsky, James J; Gill, Dipender D; Bull, Caroline J CJ; Perks, Claire M CM; , ; Davey Smith, George G; Gaunt, Tom R TR; Richardson, Tom G TG